GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ainos AIMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.60

-14.04%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$124,157

FY2016FY2025

Net income

−$14.8m

FY2016FY2025

Free cash flow

−$4.6m

FY2016FY2025

Shareholders' equity

$7.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$124,157$20,729$122,112$3.5m$594,563$16,563$11,731$77,724$250,928—
Research and development$7.7m$8.4m$7.3m$6.8m$1.9m$389$52,510$32,591——
Operating income−$14.1m−$14.2m−$13.7m−$14.0m−$3.9m−$1.4m−$1.6m−$1.3m−$579,763−$667,111
Net income−$14.8m−$14.9m−$13.8m−$14.0m−$3.9m−$1.5m−$1.6m−$1.3m−$617,375−$669,982
Diluted earnings per share-2.45-1.56-3.19-3.50-0.40-0.03-0.98-0.57-0.41-0.47

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$20.9m$28.8m$31.8m$37.1m$40.8m$260,290$596,626$1.5m$2.3m$462,676
Cash and short-term investments$417,353$3.9m$1.9m$1.9m$1.8m$22,245$409,039$1.3m$2.0m$134,125
Total liabilities$13.3m$13.3m$7.4m$2.5m$30.6m$1.1m$753,308$733,621$1.8m$1.3m
Debt$11.0m$12.0m$6.0m$1.3m$3.6m$953,000$444,581$513,356$886,481$791,481
Shareholders' equity$7.6m$15.5m$24.4m$34.6m$10.2m−$838,278−$156,682$730,079$470,795−$809,899
Shares outstanding6m10m4m4m10m42m2m2m2m1m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$4.6m−$5.8m−$4.7m−$3.0m−$1.2m−$499,551−$909,476−$1.0m−$542,703−$520,808
Capital spending−$34,561−$21,331−$92,984−$633,823−$143,792−$7,243−$13,107−$7,277−$49,096−$148,330
Free cash flow−$4.6m−$5.8m−$4.8m−$3.7m−$1.4m−$506,794−$922,583−$1.0m−$591,799−$669,138
Dividends paid——−$48,254————−$34,280——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$152$161$11,120$2,167$4,663$106,207——
Operating income−$4.4m−$2.3m−$4.3m−$2.8m−$3.9m−$3.1m−$4.5m−$3.4m
Net income−$4.6m−$2.5m−$4.5m−$2.9m−$4.1m−$3.3m−$4.7m−$3.7m
Diluted earnings per share-0.62-0.33-0.74-0.49-0.68-0.54-0.49-0.39
Cash from operations−$1.0m——−$1.0m−$1.0m−$1.0m—−$1.0m
Total assets$19.6m$22.1m$20.9m$22.7m$23.9m$26.4m$28.8m$31.4m
Cash and short-term investments$1.4m$2.8m$417,353$1.1m$1.2m$2.6m$3.9m$5.2m
Debt$13.8m$13.8m$11.0m$11.0m$11.0m$12.0m$12.0m$12.3m
Shareholders' equity$3.3m$5.7m$7.6m$10.0m$11.4m$13.1m$15.5m$18.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-67.2%49.6%51.3%
Operating income0.3%57.7%39.1%
Net income1.8%59.1%39.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-19535.5%-1476.9%-1392.4%—
Net margin-20453.4%-1516.2%-1426.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-0.7-1.5-3.2-4.4-10.6
Price to sales79.7—361.917.669.3

Share price return

Finished calendar years

20252024202320222021
Return-10%-83%-23%568%227%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 30 Jun 2025
  • 5-to-1 reverse split · 14 Dec 2023
  • 15-to-1 reverse split · 9 Aug 2022
  • 19-to-1 reverse split · 17 Dec 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.